Undeniable increase in osteoporotic fractures is associated mainly with the
global population aging. Age-related alterations shift bone metabolism to induced osteoclastic
activity and reduction of osteoblasts that consequently result in progressive bone loss. In
this case transplantation of osteoblast precursor cells, mesenchymal stem cells, may be an
option.